Pharmacological prevention of delayed hypersensitivity reactions caused by iodinated contrast media [PDF]
World Allergy Organization Journal, 2021 Background: Delayed hypersensitivity reactions (DHRs) to radiocontrast media (RCM) occur in approximately 0.5–23.0% of patients and are thought to be caused by T cell-mediated mechanisms. However, an optimal pharmacological preventive strategy is not yet
Jung-Hyun Kim +7 more
doaj +2 more sources
Delayed hypersensitivity reaction of hyaluronic acid filler (VCY-20) [PDF]
Dermatology Reports, 2023 Hyaluronic acid filler, a temporary injectable used for rejuvenating facial treatments, has gained significant popularity over the years due to its nonsurgical approach.
Christopher del Rio-Martinez +3 more
doaj +2 more sources
Afebrile vancomycin-induced delayed hypersensitivity suggestive of incomplete drug rash with eosinophilia and systemic symptoms syndrome: a case report [PDF]
Journal of Medical Case ReportsBackground Vancomycin-induced delayed hypersensitivity reactions are rare and typically accompanied by systemic symptoms such as fever, eosinophilia, and organ dysfunction, known as drug reaction with eosinophilia and systemic symptoms syndrome. However,
Chien-Hung Chou +3 more
doaj +2 more sources
Cystic fibrosis: desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor [PDF]
Frontiers in PharmacologyBackground: Cystic fibrosis transmembrane conductance regulator modulators are the only available treatment for cystic fibrosis. Although elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) is well-tolerated, rash has been reported as very frequent. In severe
L. Gómez-Ganda +9 more
doaj +2 more sources
Treatment of delayed inflammatory response to hyaluronic acid soft tissue filler in a Pfizer-Boosted Moderna-Vaccinated individual with hyaluronidaseapós reforço com vacina Pfizer com hialuronidase [PDF]
Surgical & Cosmetic Dermatology, 2022 We present a case of delayed-type hypersensitivity to hyaluronic acid (HA)-based filler on the face following the Pfizer booster in a Moderna-vaccinated individual. It is the first known case of treatment of the delayed-type
Sabine Obagi +3 more
doaj +1 more source
Biomedicines, 2023 Drug hypersensitivity reactions are classified into immediate and delayed types, according to the onset time. In contrast to the immediate type, delayed drug hypersensitivity mainly involves T lymphocyte recognition of the drug antigens and cell ...
Mu-Tzu Chu +3 more
doaj +1 more source
Swiss Medical Weekly, 2023 BACKGROUND: Corticosteroids, which are anti-inflammatory and immunosuppressive agents used for the treatment of various diseases including allergic disorders, can induce immediate and delayed hypersensitivity reactions.
Keren Mahlab-Guri +2 more
doaj +1 more source
Allergology International, 2022 Background: Skin rash often occurs upon oral administration of amoxicillin in children, due to non-immediate hypersensitivity. However, information on delayed hypersensitivity to amoxicillin is scarce.
Yukiko Katoh +5 more
doaj +1 more source
Delayed Hypersensitivity with Ferric Carboxymaltose [PDF]
Journal of Clinical and Diagnostic Research, 2017 Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of FCM. Here, we report a case of a 59-year-old
Surabhi Sridhara +3 more
doaj +1 more source
Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
Frontiers in Medicine, 2022 Delayed drug T-cell immune-mediated hypersensitivity reactions have a large clinical heterogeneity varying from mild maculopapular exanthema (MPE) to severe cutaneous adverse reactions (SCARs) such as acute generalized exanthematous pustulosis (AGEP ...
Ana Maria Copaescu +8 more
doaj +1 more source